Novel compound heterozygous POLR3A variation: expanding 4H syndrome with progressive keratoconus.
- 1Division of Pediatric Endocrinology, Department of Pediatrics, Eskişehir Osmangazi University School of Medicine, Eskişehir 26040, Türkiye.
- 2Department of Ophthalmology, Eskişehir Osmangazi University School of Medicine, Eskişehir 26040, Türkiye.
- 3Department of Medical Genetics, Eskişehir Osmangazi University School of Medicine, Eskişehir 26040, Türkiye.
Abstract
POLR3A-related leukodystrophy is a multisystem disorder classically defined by hypomyelination, hypodontia, and hypogonadotropic hypogonadism (4H syndrome). While neurological and endocrine features are well-defined, the ocular phenotypic spectrum remains incomplete. We present a 15.9-year-old female with a classic 4H phenotype and compound heterozygosity for 2 novel variants (NM_007055.4:c.2102G > T [p.(Gly701Val)] and NM_007055.4:c.2989C > T [p.(Pro997Ser)]). The patient exhibited advanced, rapidly progressive bilateral keratoconus, with a maximum keratometry (K-max) reaching an extreme 75.9 diopter (D). K-max of 75.9 D (approximately 40-47 D in children and adolescents) represents extreme corneal ectasia. Longitudinal follow-up documented progressive ectasia, treated with penetrating keratoplasty in the left eye and corneal collagen cross-linking in the right eye. On the postoperative Pentacam examination at age 22, right-eye K-max was 70.7 D (66.7 D at age 10), and the thinnest location was 304 µm; left-eye values were unreliable owing to automated quality alerts. This case highlights progressive keratoconus as a potential clinical component of POLR3A-related disorders. We propose that ribonucleic acid polymerase III is essential for corneal proteostasis. Our findings position keratoconus as a potential early clinical sentinel for 4H syndrome, necessitating mandatory corneal topography in suspected cases to ensure timely, vision-saving intervention.
Related
- Congenital hyperinsulinism as part of a multisystem disease caused by a compound heterozygous variant in the YARS1 gene
- A case of renal hypouricemia type 1 associated with compound heterozygous URAT1/SLC22A12 variants A209V and F379L: clinical evidence for their pathogenic significance
- Familial Hypomagnesemia With Hypercalciuria and Nephrocalcinosis: A Case Report of Compound Heterozygous Variants in the CLDN16 Gene Inherited From Symptomatic Heterozygous Carriers
- Case Report: Neonatal ultra-severe hemolytic anemia complicated by pulmonary hypertension induced by compound heterozygous variants in the KLF1 gene and literature review
- Comprehensive Transcriptomic and Proteomic Profiling of CILD40 with Novel Compound Heterozygous Mutations of DNAH9.
BibTeX
@article{simsek2026novel,
title = {{Novel compound heterozygous POLR3A variation: expanding 4H syndrome with progressive keratoconus.}},
author = {Enver Simsek and Tulay Simsek and Oguz Cilingir and Eray Atalay},
journal = {JCEM case reports},
year = {2026},
month = nov,
doi = {10.1210/jcemcr/luag333},
url = {https://europepmc.org/article/MED/42996498},
note = {CC BY},
}
RIS
TY - JOUR
TI - Novel compound heterozygous POLR3A variation: expanding 4H syndrome with progressive keratoconus.
AU - Enver Simsek
AU - Tulay Simsek
AU - Oguz Cilingir
AU - Eray Atalay
PY - 2026
DA - 2026/11/06
JO - JCEM case reports
DO - 10.1210/jcemcr/luag333
UR - https://europepmc.org/article/MED/42996498
AB - POLR3A-related leukodystrophy is a multisystem disorder classically defined by hypomyelination, hypodontia, and hypogonadotropic hypogonadism (4H syndrome). While neurological and endocrine features are well-defined, the ocular phenotypic spectrum remains incomplete. We present a 15.9-year-old female with a classic 4H phenotype and compound heterozygosity for 2 novel variants (NM_007055.4:c.2102G > T [p.(Gly701Val)] and NM_007055.4:c.2989C > T [p.(Pro997Ser)]). The patient exhibited advanced, rapidly progressive bilateral keratoconus, with a maximum keratometry (K-max) reaching an extreme 75.9 diopter (D). K-max of 75.9 D (approximately 40-47 D in children and adolescents) represents extreme corneal ectasia. Longitudinal follow-up documented progressive ectasia, treated with penetrating keratoplasty in the left eye and corneal collagen cross-linking in the right eye. On the postoperative Pentacam examination at age 22, right-eye K-max was 70.7 D (66.7 D at age 10), and the thinnest location was 304 µm; left-eye values were unreliable owing to automated quality alerts. This case highlights progressive keratoconus as a potential clinical component of POLR3A-related disorders. We propose that ribonucleic acid polymerase III is essential for corneal proteostasis. Our findings position keratoconus as a potential early clinical sentinel for 4H syndrome, necessitating mandatory corneal topography in suspected cases to ensure timely, vision-saving intervention.
SN - 2755-1520
ER -